What is HGH (Somatropin)?
Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.
Mechanism of Action
Growth hormone receptor agonism with downstream JAK2/STAT signaling; increases hepatic and peripheral IGF-1 production; promotes protein synthesis, lipolysis, and connective tissue remodeling
Target: Growth Hormone Receptor (GHR), IGF-1 axis
Research Indications
Direct action on endocrine system with well-characterized effects
Research and clinical use in fertility and reproductive medicine
Secondary metabolic effects through hormonal pathways
Research Protocols
These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Wellness / Anti-Aging | 1-2 IU | Daily or 5x weekly | Subcutaneous injection |
| Body Composition | 2-4 IU | Daily (often split AM/PM) | Subcutaneous injection |
| Clinical GHD Replacement | 0.15-0.3 mg | Daily | Subcutaneous injection |
| Performance (advanced) | 4-6 IU | Daily, short-term | Subcutaneous injection |
Peptide & Drug Interactions
Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.
How to Reconstitute & Inject
Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.
- 1
Remove HGH (Somatropin) vial from refrigeration and allow to reach room temperature (15–20 minutes)
- 2
Clean vial top with alcohol swab and allow to air dry completely
- 3
Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)
- 4
Inject BAC water slowly down the side of the vial — do not aim directly at the powder
- 5
Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide
- 6
Allow 2–3 minutes for full dissolution — solution should be clear and colorless
- 7
Draw calculated dose into an insulin syringe for subcutaneous injection
- 8
Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy
- 9
Store reconstituted solution refrigerated (2–8°C) and use within 28 days
What to Expect
Week 1–2
Initial effects and adaptation period. Monitor for any adverse reactions.
Week 2–4
Primary effects begin to manifest. Adjust dosing as recommended by your provider.
Week 4–8
Main therapeutic effects should be established. Assess progress with your provider.
Week 8+
Evaluate results and determine continuation, cycling, or dose adjustments.
Side Effects & Safety
- Injection site reactions (redness, bruising, mild pain)
- Potential for allergic reaction — discontinue if rash or hives occur
- Individual reactions vary — start at the lowest dose and monitor carefully
- Consult your healthcare provider before use and report any unusual symptoms
FDA Status & Regulatory Info
Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.
Frequently Asked Questions
Research References
External links for education only. We do not control third-party content.
Community-reported data
The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.
Community Intelligence
What 28 users report
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 2% · Mixed 98% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Self-reported dose per injection
Median bucket: 0–0.025 mg · Most common: 0–0.025 mg
Reports span 0 to ≥ 2 mg (open-ended top bucket)
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 88% said they felt similar to their last entry, 12% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 133 days · Based on 26 repeat reporters
Share Your Experience
Rate HGH (Somatropin) in the PeptIQ app and help the community make informed decisions.
Research purposes only
This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.